Trial site
Bunkyo Ku
- 28running trials
- 17closed trials
The trials here
What the 45 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers6 trials
- Chronic myeloid leukaemia5 trials
- Coronary artery disease3 trials
- Heart failure3 trials
- Lupus (SLE)3 trials
- Myelodysplastic syndromes3 trials
- Acute lymphoblastic leukaemia2 trials
- Diffuse large B-cell lymphoma2 trials
- Metastatic breast cancer2 trials
- Myeloproliferative neoplasms2 trials
- Polymyalgia rheumatica2 trials
- Prostate cancer2 trials
- and 19 more
- Phase
- Phase 320 trials
- Phase 210 trials
- Phase 13 trials
- Phase 42 trials
- Phase 1/21 trial
- Status
- Active, not recruiting19 trials
- Completed14 trials
- Recruiting9 trials
- Terminated3 trials
- Lead sponsor
- Novartis Pharmaceuticals45 trials
Running trials
Recruiting
A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Phase I Study of JSB462 (Luxdegalutamide) in Japanese Patients With Metastatic Prostate Cancer
Active, not recruiting
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
Active, not recruiting
Active, not recruiting
Active, not recruiting
Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers3 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Heart failure1 recruiting
- Huntington's disease1 recruiting
- Lupus (SLE)1 recruiting
- Macular degeneration1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Recruiting
Completed
Completed
Completed
Special Drug Use Observational Study With Beovu Kit for Intravitreal Injection
Completed
Completed
Completed
Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen
Completed
Study of Efficacy and Safety of Canakinumab in Japanese Patients With AOSD
Completed
Terminated
Completed
Terminated
Terminated
Completed
Completed
Completed
Completed
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Site data: ClinicalTrials.govUpdated 15 Nov 2026